The first treatment for ATTR-CM – a once-a-day tablet called tafamidis – was approved for NHS use in 2024. According to Nice, ...
Vutrisiran, which is to be administered every three months, received the green light from the National Institute for Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback